Professor Robert Field identified some overlooked issues in the gene-patenting case before the U.S. Supreme Court in a Philadelphia Inquirer article published on April 16.
Field was at the Supreme Court on April 15 for arguments in a case in which the biotech firm, Myriad Genetics, seeks to hold onto patents it holds for two genes associated with breast cancer and for a test that determines the presence of mutations linked to the disease.
An overlooked question in the case, Field wrote, is how Myriad or other biotech firms that obtain patents for genetic testing will use volumes of patient information they collect.
Field, a nationally recognized expert on health policy and health law, has covered major Supreme Court cases for the Inquirer before, most recently the Affordable Care Act case. The Inquirer also hosts Field's health law and policy blog, The Field Clinic, to which 3L Erica Cohen contributes.